KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Debt (2016 - 2023)

Medpace Holdings filings provide 7 years of Total Debt readings, the most recent being $55.0 million for Q2 2023.

  • On a quarterly basis, Total Debt fell 88.99% to $55.0 million in Q2 2023 year-over-year; TTM through Jun 2023 was $55.0 million, a 88.99% decrease, with the full-year FY2022 number at $50.0 million, changed N/A from a year prior.
  • Total Debt hit $55.0 million in Q2 2023 for Medpace Holdings, down from $115.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $499.4 million in Q2 2022 to a low of $50.0 million in Q4 2022.
  • Median Total Debt over the past 3 years was $85.4 million (2019), compared with a mean of $152.5 million.
  • Biggest five-year swings in Total Debt: tumbled 71.77% in 2019 and later plummeted 88.99% in 2023.
  • Medpace Holdings' Total Debt stood at $55.8 million in 2019, then decreased by 10.36% to $50.0 million in 2022, then increased by 10.0% to $55.0 million in 2023.
  • The last three reported values for Total Debt were $55.0 million (Q2 2023), $115.0 million (Q1 2023), and $50.0 million (Q4 2022) per Business Quant data.